Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials? Jingzhi Cai, Wengang Guo, Chuangye.

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 63, Issue 1, Pages (July 2015)

Volume 53, Issue 1, Pages (July 2010)

Volume 46, Issue 3, Pages (March 2007)

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Volume 61, Issue 4, Pages (October 2014)

Volume 50, Issue 4, Pages (April 2009)

MELD: the holy grail of organ allocation?

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”

Primary prevention of variceal haemorrhage: A pharmacological approach

Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou

Volume 61, Issue 6, Pages (December 2014)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Immigration and viral hepatitis

Volume 66, Issue 1, Pages 1-4 (January 2017)

The evidence supports a viral aetiology for primary biliary cirrhosis

New Model for End Stage Liver Disease Improves Prognostic Capability After Transjugular Intrahepatic Portosystemic Shunt Jennifer Guy, Ma Somsouk, Stephen.

Living donor liver transplantation: is the hype over?

Volume 69, Issue 2, Pages (August 2018)

The place of downstaging for hepatocellular carcinoma

Autoimmune hepatitis: A life-long disease

ART score for retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma: Is it really applicable? Jian Wu, Wei Bai,

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Andres Cardenas, Pere Ginès Journal of Hepatology

Transjugular Intrahepatic Portosystemic Shunt Does Not Alter Cerebral Blood Flow Peter Iversen, Susanne Keiding, Kim Mouridsen, Peter Ott, Hendrik Vilstrup

Transjugular intrahepatic portosystemic shunt for bleeding angiodysplasia-like lesions in portal-hypertensive colopathy Christoph Balzer, Erich Lotterer,

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Use of hemospray for non-variceal esophageal bleeding in an infant

Volume 41, Issue 4, Pages (October 2004)

Volume 57, Issue 5, Pages (November 2012)

Volume 53, Issue 6, Pages (December 2010)

Volume 50, Issue 4, Pages (April 2009)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Paul C. Adams, James C. Barton Journal of Hepatology

Immigration and viral hepatitis

The potential of induced pluripotent stem cell derived hepatocytes

Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability Markus Cornberg,

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

Volume 152, Issue 1, Pages (January 2017)

The impact of intestinal microflora on serum bilirubin levels

Esophageal variceal bleeding: Primary prophylaxis

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

Table of contents The Journal for Nurse Practitioners

The use of hemospray in portal hypertensive bleeding; a case series

Incarcerated Umbilical Hernia After Transjugular Intrahepatic Portosystemic Shunt Procedure for Refractory Ascites Ravi K. Mallavarapu, Edwin W. Grimsley

New trials and results in systemic treatment of HCC

Liver transplantation in children

Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi

Vegetative infection of transjugular intrahepatic portosystemic shunts

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Genetics of hepatocellular carcinoma: The next generation

MELD: the holy grail of organ allocation?

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child

Presentation transcript:

Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials? Jingzhi Cai, Wengang Guo, Chuangye He, Guohong Han Journal of Hepatology Volume 62, Issue 1, Pages 245-247 (January 2015) DOI: 10.1016/j.jhep.2014.08.053 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Shunt dysfunction caused by stent displacement in a 62-year-old woman. (A) Stent implantation (arrow) during the TIPS procedure. (B) The patient developed variceal bleeding, and portography confirmed the displacement of the stent (arrow). (C) A new stent was inserted (arrow) in the revision. Journal of Hepatology 2015 62, 245-247DOI: (10.1016/j.jhep.2014.08.053) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions